GSK
About
Pharmaceutical company that purchased Sinclair's resveratrol research for 720 million dollars, then abandoned it after finding no benefit
Cast within
No topic-region cast yet — this appears once GSK's compiled claims are aligned into a topic region's argument tree.
Claims by GSK (0)
No claims found for this person.
Your notes
Loading notes...